Clinical Trials · NCT03352869
Research of Exenatide for Overweight/Obese PCOS Patients With IGR
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- RenJi Hospital
- Enrollment
- 183
- Start date
- Nov 2017
- Locations
- 1 site, China
- Primary endpoint
- Improvement of intravenous blood glucose from impaired glucose regulation to normal glucose regulation